MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-MH-19-0050078
Marvel Drugs Pvt Ltd
Marvel Drugs Pvt Ltd - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹11.53 Cr
▼ 25% YoY
Net profit · FY 2025
₹1.57 Cr
Net margin 13.6%
EBITDA · FY 2025
₹2.38 Cr
EBITDA margin 20.6%
Authorised capital
₹50 Lakh
Registered with MCA
Paid-up capital
₹50 Lakh
Issued & subscribed
Open charges
₹1.27 Cr
Secured borrowings
Company age
40 yrs
Est. 1986
Employees · EPFO
34
Provident fund records
About Marvel Drugs Pvt Ltd
Data last updated:
Marvel Drugs Pvt Ltd is a private limited company based in Mumbai, Maharashtra, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 19 May 1986 and has been in existence for over 40 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH1986PTC039868. Its GSTIN is 27AAACM4655N1Z2 (Maharashtra).
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹50 Lakh. It is led by directors Nikhil Jitendra Shah (Managing Director) and Abhishek Nikhil Shah.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 20 Nagin Mahal 5th Floor 82 Veer Nariman Road Churchgate, Mumbai, Maharashtra, India – 400020.
As per the financials filed for FY 2025, the company reported a revenue of ₹11.53 Cr, a decline of 25% compared to the previous year. For the same year it recorded a net profit of ₹1.57 Cr (net margin 13.6%) and EBITDA of ₹2.38 Cr (EBITDA margin 20.6%). Revenue has declined at a compounded annual rate (CAGR) of 11% over three years and 4% over five years.
The company has about 34 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹1.27 Cr on record. Court records list 6 cases involving the company, including 2 filed by the company and 4 filed against it; 2 cases are pending.
Marvel Drugs Pvt Ltd is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0050078). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24230MH1986PTC039868
Registration Number 039868
Incorporation Date 19 May 1986
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-MH-19-0050078
Recognitions & Rankings of Marvel Drugs
Contact details
Marvel Drugs Pvt Ltd's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address20 Nagin Mahal 5th Floor 82 Veer Nariman Road Churchgate, Mumbai, Maharashtra, India – 400020
- IndustryPharma, API Manufacturers
To see the full contact details of Marvel Drugs Pvt Ltd, buy the company report.
Comprehensive company report
Marvel Drugs Pvt Ltd - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Marvel Drugs is manufacturing. In detail, this covers manufacture of chemicals and chemical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 20 | Manufacture of chemicals and chemical products |
To see the full business activity and turnover split of Marvel Drugs Pvt Ltd, buy the company report.
Financials of Marvel Drugs Pvt Ltd
FY 2024 filings availableMarvel Drugs Pvt Ltd reported revenue of ₹11.53 Cr (down 25% YoY) for FY 2025.
Revenue · FY 2025
₹11.53 Cr ▼ 25%
Net profit · FY 2025
₹1.57 Cr margin 13.6%
EBITDA · FY 2025
₹2.38 Cr margin 20.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 25%
3 years · compounded
▼ 11%
5 years · compounded
▼ 4%
EBITDA CAGR growth
1 year
▼ 46%
3 years · compounded
▼ 24%
5 years · compounded
▼ 6%
Revenue has declined at a compounded annual rate (CAGR) of 4% over five years, including a 25% fall in the latest year. EBITDA fell 46% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.38 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.57 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 20.6% | ||||
| Net Profit Margin | 13.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Marvel Drugs Pvt Ltd, buy the company report.
Board of directors of Marvel Drugs Pvt Ltd
Marvel Drugs has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nikhil Jitendra Shah | Managing Director | 21 Sep 1987 | 39 Years 1 Months | Current |
| Abhishek Nikhil Shah Also directs: Wellthy Therapeutics Private Limited | Director | 19 Dec 2002 | 23 Years 10 Months | Current |
Auditor
Marvel Drugs Pvt Ltd is audited by FKMody& CO for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| FKMody& CO | FY 2022 | 115205W |
Shareholding
The shareholding of Marvel Drugs Pvt Ltd is on record for 5 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Marvel Drugs Pvt Ltd, buy the company report.
Charges & borrowings
Open charges
₹1.27 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 19 Apr 2022 | 100570663 | The Hongkong and Shanghai Banking Corporation Limited | ₹29 Lakh | Open | |
| 24 Jan 2017 | 100077774 | The Hongkong and Shanghai Banking Corporation Limited | ₹2 Lakh | Open | |
| 09 Mar 2016 | 10628027 | The Hongkong and Shanghai Banking Corporation Limited | ₹2 Lakh | Open | |
| 17 Jul 1987 | 90162074 | Bank of India | ₹12 Lakh | Open | |
| 11 Dec 1986 | 90162005 | Bank of India | ₹70 Lakh | Open |
To see the full charge records of Marvel Drugs Pvt Ltd, buy the company report.
Total charge records: 6 View all charges
Legal cases
Marvel Drugs Pvt Ltd has 6 court cases on record: 2 filed by Marvel Drugs, 4 filed against it. 2 cases are pending and 4 are disposed.
Total cases
6
Filed by the company
2
Filed against the company
4
Pending
2
Disposed
4
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 3 | 3 | 2 |
| High courts | 2 | 0 | 0 |
| Supreme Court | 1 | 1 | 0 |
Cases on record (5 of 6)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Supreme Court | Court case (3801-Matters Relating To Consumer Protection : Appeals u/s 23 of Consumer Protection Act, 1986.) | Filed against the company by United India Insurance Co.Ltd. | Disposed |
| District court, Raigad, Maharashtra | Civil suit | Filed against the company by M R Nikam Inspector Under Maharashtra Private Security Guards Board Raigad | Pending |
| District court, Raigad, Maharashtra | Court case (R.C.C.) | Filed against the company by Maharashtra Pollution Control Board | Pending |
| Bombay High Court | Writ petition | Filed by the company against Deputy Commissioner of Income-Tax Circle - 6(3) and Another | Disposed |
| Bombay High Court | Writ petition | Filed by the company against Deputy Commissioner of Income-Tax Mumbai and Another | Disposed |
To see the full case history of Marvel Drugs Pvt Ltd, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Marvel Drugs Pvt Ltd has 4 MSME Form 1 returns on record between 2017 and 2020, listing 181 overdue payments to 61 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 61)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Dhalkot Industries | |||
| an individual supplier | |||
| an individual supplier | |||
| an individual supplier | |||
| an individual supplier |
To see the full MSME payment records of Marvel Drugs Pvt Ltd, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Marvel Drugs Pvt Ltd has a workforce of 34 employees on its EPFO records as of Apr 02, 2024, across 1 active EPFO establishment.
Employee count
34
Active EPFO establishments
1
Employee growth
-10.53%
GST
Marvel Drugs has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACM4655N1Z2 | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Marvel Drugs Pvt Ltd, buy the company report.
Recent activity
Marvel Drugs Pvt Ltd has 3 board changes on record since 1987: 2 appointments and 1 cessation. The latest: Jitendra Manilal Shah ceased to be Director on 18 Aug 2011.
AGM
Marvel Drugs Pvt Ltd last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Marvel Drugs Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
Charges
A charge with The Hongkong And Shanghai Banking Corporation Limited amounted to Rs. 29.00 Lakh with Charge ID 100570663 was registered on 19 Apr 2022.
Charges
A charge with The Hongkong And Shanghai Banking Corporation Limited amounted to Rs. 2.00 Lakh with Charge ID 100077774 was registered on 24 Jan 2017.
Charges
A charge with The Hongkong And Shanghai Banking Corporation Limited amounted to Rs. 2.00 Lakh with Charge ID 10628027 was registered on 09 Mar 2016.
Ceased
Jitendra Manilal Shah ceased to be Director.
Appointed
Abhishek Nikhil Shah was appointed as Director.
Charges
A charge with Bank Of India of Rs. 12.00 Lakh registered on 18 Aug 1986 with Charge ID 90161972 was modified on 28 Jan 1998.
Charges
A charge with Bank Of India of Rs. 70.00 Lakh registered on 11 Dec 1986 with Charge ID 90162005 was modified on 19 Sep 1990.
Charges
A charge with Bank Of India of Rs. 12.00 Lakh registered on 17 Jul 1987 with Charge ID 90162074 was modified on 05 May 1990.
Appointed
Nikhil Jitendra Shah was appointed as Managing Director.
Charges
A charge with Bank Of India amounted to Rs. 12.00 Lakh with Charge ID 90162074 was registered on 17 Jul 1987.
3 earlier events are in the company report.
Frequently asked questions
Marvel Drugs is an active private limited company based in Mumbai, Maharashtra, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 19 May 1986 (40+ years old) and is registered under CIN U24230MH1986PTC039868.
Marvel Drugs has 2 current directors:
- Nikhil Jitendra Shah - Managing Director
- Abhishek Nikhil Shah - Director
The latest financial statements of Marvel Drugs on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Marvel Drugs is 27AAACM4655N1Z2, registered in Maharashtra.
The CIN (Corporate Identification Number) of Marvel Drugs is U24230MH1986PTC039868. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Marvel Drugs has 6 court cases on record: 2 filed by the company and 4 filed against it. 2 are pending. Most are in the district courts.
Marvel Drugs was incorporated on 19 May 1986, making it 40+ years old. It is registered with the Registrar of Companies, Mumbai.
Jitendra Manilal Shah ceased to be Director on 18 Aug 2011. Abhishek Nikhil Shah was appointed as Director on 19 Dec 2002. Nikhil Jitendra Shah was appointed as Managing Director on 21 Sep 1987.
Yes, Marvel Drugs is registered as a small enterprise under Udyam registration (number: UDYAM-MH-19-0050078).
Marvel Drugs has 4 MSME Form 1 returns on record between 2017 and 2020, listing 181 overdue payments to 61 micro and small suppliers. The latest return was filed on 27 May 2021.
The registered office of Marvel Drugs is at 20 Nagin Mahal 5th Floor 82 Veer Nariman Road Churchgate, Mumbai, Maharashtra, India – 400020.